KALA supply chain intelligence for KALA BIO, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
KALA BIO, Inc. (KALA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| 2624465-ONTARIO-INC-O-A-YOUNET-AI | 2624465-ONTARIO-INC-O-A-YOUNET-AI | 90% | Pursuant to the Agreement, Younet shall also provide to the Company certain deliverables and services related to the Researgency Platform |
| BAKER-BROS-ADVISORS-LP | BAKER-BROS-ADVISORS-LP | 90% | the Company agreed to issue 900,000 shares of its common stock to resolve certain claims relating to participation rights under prior financing arrangements |
| DELAWARE-IR-LLC | DELAWARE-IR-LLC | 90% | Delaware IR agreed to provide marketing and advertising services for a six-month term for $600,000 |
| LIFESCI-CAPITAL-LLC | LIFESCI-CAPITAL-LLC | 90% | the Company agreed to issue 2,200,000 shares of Common Stock to settle certain payment obligations for financial advisory services |
| MINGLEMINT-SOLUTIONS-LLC | MINGLEMINT-SOLUTIONS-LLC | 90% | Secured Promissory Note, dated as of February 9, 2026, by and between the Company and Minglemint Solutions LLC |
| WAINWRIGHT | WAINWRIGHT | 90% | The Company will pay Wainwright a sales commission equal to 3.0% of the gross sales price of the shares of Common Stock sold by Wainwright |
| YOUNET | YOUNET | 90% | Pursuant to the Agreement, Younet agreed to provide us certain deliverables and services related to the Researgency Platform |
| YOUNET-AI | YOUNET-AI | 90% | Pursuant to the Agreement, Younet shall also provide to the Company certain deliverables and services related to the Researgency Platform |
| STANFORD | STANFORD | 80% | Under the Stanford Agreement, the Company is required to pay Stanford annual license maintenance fees |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| AK-HOLDINGS | AK-HOLDINGS | 62% | eatment of PCED, a rare disease of impaired corneal healing. Based on the results of a Phase 1b clinical safety and efficacy trial of KPI-012 in patients with PCED, we submitted an investigational ne… |
| AK-HOLDINGS-GROUP-INC | AK-HOLDINGS-GROUP-INC | 62% | eatment of PCED, a rare disease of impaired corneal healing. Based on the results of a Phase 1b clinical safety and efficacy trial of KPI-012 in patients with PCED, we submitted an investigational ne… |
| CATALYST-PHARMS-INC | CATALYST-PHARMS-INC | 62% | platform involves the collection, storage and transmission of confidential and proprietary information belonging to our customers, including personal identifying information, clinical trial data and … |
| CO-LLC | CO-LLC | 62% | eatment of PCED, a rare disease of impaired corneal healing. Based on the results of a Phase 1b clinical safety and efficacy trial of KPI-012 in patients with PCED, we submitted an investigational ne… |
| DELAWARE-IR-LLC | DELAWARE-IR-LLC | 62% | settlements and $0.9 million gain on Menlo Park lease settlement, partially offset by $0.5 million loss on disposal of fixed assets. There was no other expense, net for the year ended December 31, 20… |
| JEF | Jefferies Financial Group Inc. | 62% | Reciprocal relationship from JEF graph: Reciprocal relationship from KALA graph: Reciprocal relationship from JEF graph: Reciprocal relationship from KALA graph: Reciprocal relationship from JEF grap… |
| JEFFERIES-LLC | JEFFERIES-LLC | 62% | eatment of PCED, a rare disease of impaired corneal healing. Based on the results of a Phase 1b clinical safety and efficacy trial of KPI-012 in patients with PCED, we submitted an investigational ne… |
| LIFESCI-CAPITAL-LLC | LIFESCI-CAPITAL-LLC | 62% | settlements and $0.9 million gain on Menlo Park lease settlement, partially offset by $0.5 million loss on disposal of fixed assets. There was no other expense, net for the year ended December 31, 20… |
| MINGLEMINT-SOLUTIONS-LLC | MINGLEMINT-SOLUTIONS-LLC | 62% | eatment of PCED, a rare disease of impaired corneal healing. Based on the results of a Phase 1b clinical safety and efficacy trial of KPI-012 in patients with PCED, we submitted an investigational ne… |
| OXFORD-FINANCE-LLC | OXFORD-FINANCE-LLC | 62% | eatment of PCED, a rare disease of impaired corneal healing. Based on the results of a Phase 1b clinical safety and efficacy trial of KPI-012 in patients with PCED, we submitted an investigational ne… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| KALA-DEBT-10483 | Warrants outstanding: 1900000 | 90% | xbrl warrant detail from xbrl 2018-12-31. |
| KALA-DEBT | Debt stack $47.2M | 90% | Market cache reports total debt of $47.2M. |
| KALA-DEBT-10484 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2017-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| KALA-OWNER-ADAR1-CAPITAL-MANAGEMENT-LLC | Adar1 Capital Management, LLC | 95% | 13F/ownership overlay lists Adar1 Capital Management, LLC ; shares held 141,480; ownership 0.02%; value $30,771; as of 2025-12-31. |
| KALA-OWNER-WOODLINE-PARTNERS-LP | Woodline Partners LP | 95% | 13F/ownership overlay lists Woodline Partners LP; shares held 224,174; ownership 0.02%; value $48,757; as of 2025-12-31. |
| KALA-OWNER-JANE-STREET-GROUP-LLC | Jane Street Group, LLC | 95% | 13F/ownership overlay lists Jane Street Group, LLC; shares held 144,347; ownership 0.02%; value $31,395; as of 2025-12-31. |
| KALA-OWNER-BAKER-BROS-ADVISORS-LP | Baker Bros. Advisors, LP | 95% | 13F/ownership overlay lists Baker Bros. Advisors, LP; shares held 1,804,055; ownership 0.20%; value $392,381; as of 2025-12-31. |
| KALA-OWNER-VIRTU-FINANCIAL-LLC | Virtu Financial LLC | 95% | 13F/ownership overlay lists Virtu Financial LLC; shares held 85,505; ownership 0.01%; value $18,597; as of 2025-12-31. |
| KALA-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | Geode Capital Management, LLC | 95% | 13F/ownership overlay lists Geode Capital Management, LLC; shares held 61,161; ownership 0.01%; value $13,302; as of 2025-12-31. |
| KALA-OWNER-CITADEL-ADVISORS-LLC | Citadel Advisors Llc | 95% | 13F/ownership overlay lists Citadel Advisors Llc; shares held 56,381; ownership 0.01%; value $12,262; as of 2025-12-31. |
| KALA-OWNER-STATE-STREET-CORPORATION | State Street Corporation | 95% | 13F/ownership overlay lists State Street Corporation; shares held 28,576; value $6,215; as of 2025-12-31. |
| KALA-OWNER-RENAISSANCE-TECHNOLOGIES-LLC | Renaissance Technologies, LLC | 95% | 13F/ownership overlay lists Renaissance Technologies, LLC; shares held 40,905; value $8,896; as of 2025-12-31. |
| KALA-OWNER-VANGUARD-GROUP-INC | Vanguard Group Inc | 95% | 13F/ownership overlay lists Vanguard Group Inc; shares held 91,009; ownership 0.01%; value $19,794; as of 2025-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| JEF | Jefferies Financial Group Inc. | 100.00 | 1 | ['customer'] |
| SMBC | Southern Missouri Bancorp, Inc. | 50.00 | 2 | |
| CTMX | CytomX Therapeutics, Inc. | 50.00 | 2 | |
| ARDX | Ardelyx, Inc. | 50.00 | 2 | |
| BRK-B | Berkshire Hathaway Inc. | 50.00 | 2 | |
| FORTY | Formula Systems (1985) Ltd. | 50.00 | 2 | |
| FNMAS | Federal National Mortgage Association | 50.00 | 2 | |
| FMCKI | Federal Home Loan Mortgage Corporation | 50.00 | 2 | |
| LGN | Legence Corp. | 50.00 | 2 | |
| PRTC | PureTech Health plc | 50.00 | 2 | |
| SF | Stifel Financial Corp. | 50.00 | 2 | |
| SMFG | Sumitomo Mitsui Financial Group, Inc. | 50.00 | 2 | |
| SMFNF | Sumitomo Mitsui Financial Group, Inc. | 50.00 | 2 | |
| SELLER | SELLER | 50.00 | 2 | |
| VTS | Vitesse Energy, Inc. | 50.00 | 2 | |
| VRA | Vera Bradley, Inc. | 50.00 | 2 | |
| FREJP | FEDERAL HOME LOAN MORTGAGE CORP | 50.00 | 2 | |
| WAL | Western Alliance Bancorporation | 50.00 | 2 | |
| KYTX | Kyverna Therapeutics, Inc. | 50.00 | 2 | |
| MBX | MBX Biosciences, Inc. | 50.00 | 2 |